The global interventional oncology market size was US$ 2.1 billion in 2021. The global interventional oncology market size is forecast to reach US$ 3.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2022 to 2030.
Interventional oncology (IO) is an emerging subspecialty that focuses on using image-guided procedures (diagnostics/surgeries) to improve cancer therapy. Along with surgery, medication, and radiation, IO is currently the fourth pillar of modern oncology care. The three key areas of cancer intervention that IO focuses on are therapy, diagnosis, and symptom relief. Advances in cross-sectional imaging modalities like ultrasound, magnetic resonance (MR), computed tomography (CT), and positron emission tomography (PET) have enabled progress in IO (PET).
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market. Several governments worldwide implemented a lockdown in order to curb the spread of the COVID-19 virus. This disrupted both sellers' and purchasers' demands. In addition, the COVID-19 pandemic has had a significant impact on IO activity in cancer centers and hospitals. Clinics and hospitals in the majority of countries have converted their operating rooms into intensive care units (ICUs) and mobilized oncologists to combat the COVID-19 patients. These factors have had a negative impact on the worldwide interventional oncology industry.
Regional Analysis
North America garnered the major share of the global market in 2021 and is forecast to remain dominant during the forecast period. As a result of the growing population with chronic cancer such as hepatocellular carcinoma, lung cancer, renal cancer, and metastatic colorectal cancer. In addition, substantial adoption of minimally invasive surgeries for the adequate management of cancer, well-established healthcare infrastructure, and increasing adoption of technologically advanced interventional oncology products. Thus, these factors fuel the market growth in the region.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the increased prevalence of cancer in the high population countries such as India and China, rapidly transforming healthcare systems, diverse government initiatives to enhance overall healthcare, and growing per capita healthcare expenditure. In addition, increasing investments by leading global interventional oncology companies are forecast to drive the market growth in the region.
Leading Competitors
The leading prominent companies profiled in the global interventional oncology market are:
Scope of the Report
The global interventional oncology market segmentation focuses on Product Type, Cancer Type, End-User, and Region.
Segmentation based on Product Type
Segmentation based on Cancer Type
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL INTERVENTIONAL ONCOLOGY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL INTERVENTIONAL ONCOLOGY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 EMBOLIZATION DEVICES
5.3 ABLATION DEVICES
5.4 SUPPORT DEVICES
6 GLOBAL INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE
6.1 OVERVIEW
6.2 LIVER CANCER
6.3 LUNG CANCER
6.4 BREAST CANCER
6.5 PROSTATE CANCER
6.6 KIDNEY CANCER
6.7 BONE METASTASIS
6.8 OTHER CANCERS
7 GLOBAL INTERVENTIONAL ONCOLOGY MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 AMBULATORY SURGERY CENTERS
7.4 RESEARCH AND ACADEMIC INSTITUTES
7.5 OTHERS
8 GLOBAL INTERVENTIONAL ONCOLOGY MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL INTERVENTIONAL ONCOLOGY MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 MEDTRONIC, INCORPORATED
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 BOSTON SCIENTIFIC CORPORATION
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 BECTON, DICKINSON, AND COMPANY
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 TERUMO CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 MERIT MEDICAL
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 ANGIODYNAMICS
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 JOHNSON & JOHNSON
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 TELEFLEX INCORPORATED
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 COOK GROUP
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 HEALTHTRONICS, INCORPORATED
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved